載入...
Intravenous Alpha-1 Antitrypsin Therapy for Alpha-1 Antitrypsin Deficiency: The Current State of the Evidence
Alpha-1 antitrypsin deficiency (AATD) is a largely monogenetic disorder associated with a high risk for the development of chronic obstructive pulmonary disease (COPD) and cirrhosis. Intravenous alpha-1 antitrypsin (AAT) therapy has been available for the treatment of individuals with AATD and COPD...
Na minha lista:
| 發表在: | Chronic Obstr Pulm Dis |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
COPD Foundation Inc
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6373587/ https://ncbi.nlm.nih.gov/pubmed/30775428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.1.2017.0185 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|